How AI Is Reshaping Pharma’s Commercial Operations with Punit Kumar

Episode notes

In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Punit Kumar, the Executive Director of Customer Engagement for the US Enterprise Portfolio at Novartis, to dive into why execution excellence matters more than hype, how AI agents are freeing up your team from manual work to focus on high-impact insights, and the counterintuitive skill that matters most in pharma today: getting comfortable being uncomfortable. Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice. The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

• Pharma’s Biggest Blind Spot: Why 99.9% of Chemical Space Was Never Explored | Dr. Olga Nissan, Ph.D. - Vice President of Business Development, EvogeneProgress, Potential, and Possibilities Podcast / Show · on AI in Pharma
• AI, Ethics, Leadership and the Future of Pharma: Dr. Laurie Myers, CEO of Hallett Davis Strategic Group | Ep. 44Industry Ignited Podcast · on AI in Pharma

• Hallway Interviews with Pharma Learning Leaders73 / 100
• Blockchain + AI: The Future of Healthcare Data70 / 100
• The Question Behind the Question - Field Training with Jennifer Muszik67 / 100
• Why the Small Details Reveal Everything About Your CDMO Partner with Frank Sorce66 / 100
• Why Medical Knowledge Isn’t Reaching Patients with Dr. Simon Chowdhury69 / 100